TABLE E2.
Induction of lymphoproliferative responses with nDer p 1, rDer p 2, and the rDer p 2/1C and rDer p 2/1S mosaic proteins
| 0.1 μmol/L Allergen |
0.025 μmol/L Allergen |
|||||||
|---|---|---|---|---|---|---|---|---|
| nDer p 1 | rDer p 2 | rDer p 2/1C | rDer p 2/1S | nDer p 1 | rDer p 2 | rDer p 2/1C | rDer p 2/1S | |
| Patient 2 | 6.9 | 4.9 | 6.4 | 3.8 | 4.7 | 2.7 | 7.2 | 2.1 |
| Patient 5 | 3.1 | 3.2 | 4.7 | 3.3 | 3.4 | 4.3 | 5.0 | 2.1 |
| Patient 6 | 3.3 | 2.5 | 2.6 | 4.1 | 3.3 | 2.9 | 2.4 | 2.0 |
| Patient 7 | 2.1 | 3.0 | 1.8 | 1.6 | 2.1 | 3.7 | 2.6 | 2.4 |
| Patient 10 | 4.2 | 2.6 | 1.9 | 3.0 | 4.8 | 3.9 | 1.7 | 2.5 |
| Patient 12 | 2.5 | 2.3 | 3.3 | 2.7 | 2.9 | 2.2 | 2.7 | 3.8 |
| Patient 13 | 2.5 | 2.7 | 3.0 | 5.0 | 2.9 | 2.8 | 2.9 | 4.2 |
| Patient 18 | 3.8 | 4.6 | 5.3 | 6.7 | 5.4 | 4.1 | 4.2 | 5.2 |
| Patient 23 | 2.2 | 2.9 | 1.6 | 1.6 | 2.3 | 3.8 | 1.2 | 2.4 |
PBMCs from patients with HDM allergy were stimulated with different concentrations of the proteins, and stimulation indices are displayed.